The safe use of Doliocarpus dentatus in the gestational period: Absence of changes in maternal reproductive performance, embryo-fetal development and DNA integrity. (10th May 2018)

• Record Type: Journal Article
• Authors: Ishikawa, Raissa Borges; Vani, Juliana Miron; das Neves, Silvia Cordeiro; Rabacow, Ana Paula Maluf; Kassuya, Cândida Aparecida Leite; Croda, Júlio; Cardoso, Claudia Andrea Lima; Monreal, Antônio Carlos Duenhas Ferreira; Antoniolli, Andreia Conceição Milan Brochado; Cunha – Laura, Andréa Luiza; Oliveira, Rodrigo Juliano
• Is Part Of: Journal of ethnopharmacology. Volume 217(2018)
• Page Start: 1
• Page End: 6
• Publication Date: 2018-05-10
• Subjects: Doliocarpus dentatus -- Teratogenesis -- Reproductive toxicology; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2018.01.034
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: Doliocarpus dentatus (Dilleniaceae) is commonly used in Brazil for the treatment of inflammatory process pain and urinary retention. Previous studies of our group have demonstrated the anti-inflammatory and antimycobacterial action of the ethanolic extract of Doliocarpus dentatus (EEDd) as well as the safety of its use. Aim of the study: we investigated the effects of EEDd on reproductive performance, fetal development and DNA integrity in pregnant female Swiss mice. Material and methods: thirty female Swiss mice were divided into three experimental groups (n = 10): control group treated with 1% tween-80 and EEDd1 and EEDd2 groups treated with EEDd at doses of 100 and 1000 mg/kg, respectively. The treatment occurred by oral gavage throughout the gestational period. At the end of pregnancy, parameters related to reproductive performance, embryofoetal development and DNA integrity was evaluated. Results: both doses of the extract tested did not alter the reproductive parameters, did not present significant differences in the embryofetal development when compared to the control group and also did not induce the formation of micronuclei. Conclusion: the EEDd do not alter the reproductive parameters, embryofetal development and DNA integrity, ensuring its safe use during pregnancy. Graphical abstract: